Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Cancer Genetics, Inc.

NASDAQ: CGIXHealthcare / Medical Laboratories & Research / USA
0.2600+0.0100+4.00%Vol 16 0631Y Perf -85.15%
Mar 18th, 2019 09:57
BID0.2500 ASK0.2600
Open0.2600 Previous Close0.2500
Pre-Market- After-Trading0.26
 - -%  0.01 4.00%
Target Price
4.50 
Analyst Rating
Moderate Buy 2.00
Potencial %
1 700.00 
Finscreener Ranking
     41.28
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
     29.65
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
+     29.93
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)7 
Earnings Rating
Sell
Price Range Ratio 52wk %
3.00 
Earnings Date
1st Apr 2019

Today's Price Range

0.25000.2600

 

52wk Range

0.20002.20

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-3.85%
3 Months
-55.36%
6 Months
-75.96%
1 Year
-85.15%
3 Years
-89.67%
5 Years
-98.58%

Name / TickerPriceChg.Chg.%
CGIX0.26000.01004.00
AAPL187.110.99000.53
GOOG1 183.47-0.9900-0.08
MSFT116.911.00000.86
XOM81.090.94001.17
WFC51.460.80001.58
JNJ136.96-0.6400-0.47
FB161.84-4.1400-2.49
GE10.080.12001.20
JPM107.170.62000.58
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.40
Current Ratio
0.50
Long Term Debt to Total Capital
0.05
Total Debt to Equity
1.28
Interest Coverage
-8.80
Leverage Ratio 2.70
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
29.60
EBIT Margin
-81.70
EBITDA Margin
-74.00
Pre-tax Profit Margin
-104.20
Profit Margin
-80.45
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
20 643
Revenue per Share
0.50
Revenue Growth 3 Years
7.86
Revenue Growth 5 Years
32.26

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.16-0.23-43.75
Q02 2018-0.13-0.130.00
Q01 2018--0.16-
Q04 2017--0.35-
Q03 2017-0.13-0.16-23.08
Q02 2017-0.16-0.160.00
Q01 2017-0.18-0.1138.89
Q04 2016-0.22-0.1531.82
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.130.00-
12/2018 FY-0.580.00-
3/2019 QR-0.070.00-
12/2019 FY-0.110.00-
Next Report Date1st Apr 2019
Estimated EPS Next Report-0.13
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume16 063
Shares Outstanding (in ths.)27 725
Trades Count10
Dollar Volume2 066
Avg. Volume2 376 601
Avg. Weekly Volume642 194
Avg. Monthly Volume1 120 008
Avg. Quarterly Volume2 225 353

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

31%69%

Bearish Bullish

43%57%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News